Appulse Medical

Appulse Medical was a North American wound care commercial organization launched by Aroa Biosurgery and Hydrofera to market and sell complementary wound care products in the United States and Canada. Its portfolio centered on Aroa's Endoform extracellular matrix products and Hydrofera Blue antibacterial foam dressings for acute and chronic wound management. The business appears to have functioned primarily as a shared sales force and distribution platform rather than as a drug-development biotech company. In February 2021, Hydrofera and Aroa announced that they would discontinue the Appulse Medical shared-sales arrangement and transition to separate dedicated sales teams beginning March 1, 2021. Based on that public disclosure, Appulse Medical does not appear to remain an active standalone operating company today.